## Abstract Nanocomposites from polyether‐type waterborne polyurethane (PU) incorporated with different amounts of gold nanoparticles (17.4–65 ppm) or silver nanoparticles (30.2–113 ppm) were prepared. Specifically, the nanocomposite containing 43.5 ppm of gold or 30.2 ppm of silver was previously
Enhanced Biocompatibility in Biostable Poly(carbonate)urethane
✍ Scribed by Shan-hui Hsu; Yu-Chih Kao; Zu-Chang Lin
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 227 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1616-5187
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Summary: In this work, we synthesized two MDI‐based polyurethanes, including a poly(ether)urethane (PEU) and a poly(carbonate)urethane (PCU), by using different soft segments, poly(tetramethylene oxide) and poly(hexyl, ethyl)carbonate diol ($\overline M$ ∼ 2 000). We demonstrated that, in addition to the enhanced biostability of PCU over PEU, the biological performances of PCU in vitro were also improved in general. These included, better cellular attachment and proliferation, less platelet activation, as well as reduced monocyte activation. The unusual wide‐ranging enhancement in biocompatibility for PCU was believed to be related to the larger micro‐phase separation in PCU (∼25 nm) that caused distinct protein adsorption on the surface.
The total number of adherent monocytes (nonactivated and activated) on the bare sample surfaces, albumin pre‐adsorbed sample surfaces, and fibrinogen pre‐adsorbed sample surfaces.
imageThe total number of adherent monocytes (nonactivated and activated) on the bare sample surfaces, albumin pre‐adsorbed sample surfaces, and fibrinogen pre‐adsorbed sample surfaces.
📜 SIMILAR VOLUMES
## Abstract **Summary:** Nanophase separation has been suggested to influence the biological performance of polyurethane. In a previous work (__Macromol. Biosci__. **2004**, __4__, 891), six different 4,4′‐diphenylmethane diisocyanate (MDI)‐based poly(carbonate urethane)s (PCUs) that exhibited vari
## Abstract Several strategies have been used to increase the biostability of medical‐grade polyurethanes while maintaining biocompatibility and mechanical properties. One approach is to chemically modify or replace the susceptible soft segment. Currently, poly(carbonate urethanes) (PCUs) are being
## Abstract This study compared the effect of an antioxidant on the __in vivo__ biodegradation of a poly(carbonate urethane) (PCU) and a poly(ether urethane) (PEU). Unstrained PEU and PCU films with and without Santowhite® were implanted subcutaneously into 3‐month‐old Sprague‐Dawley rats for 3, 6,
## Abstract This study used an __in vitro__ environment that simulated the microenvironment at the adherent cell‐material interface to reproduce and accelerate the biodegradation of poly(ether urethane) (PEU) and poly(carbonate urethane) (PCU). Polyurethane films were treated __in vitro__ for 24 da
## Abstract In this study, a fatty acid urethane derivative of dehydroepiandrosterone (DHEA) was synthesized and evaluated as a polyurethane additive to increase long‐term biostability. The modification was hypothesized to reduce the water solubility of the DHEA and physically anchor the additive i